<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="216661">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00264524</url>
  </required_header>
  <id_info>
    <org_study_id>CMU93-M-34</org_study_id>
    <nct_id>NCT00264524</nct_id>
  </id_info>
  <brief_title>DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <brief_summary>
    <textblock>
      The current study was designed to determine whether the HLA-DRB1, DQA1, DQB1 alleles are
      associated with the risk and the pattern of valve damage of RHD.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date>July 2005</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <condition>Rheumatic Heart Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>venipuncture to withdraw patient's blood</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1.Patients with Rheumatic mitral stenosis 2.Chinese Han ethnicity

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Hsiang-Tai Chou, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>China Medical University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of cardiology, China Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>403</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>January 2004</verification_date>
  <lastchanged_date>November 26, 2010</lastchanged_date>
  <firstreceived_date>December 12, 2005</firstreceived_date>
  <keyword>Rheumatic heart disease, HLA, Genetics, Taiwan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Rheumatic Heart Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
